HLA-A and colorectal cancer: As controls, we used HLA-A*02:01− integrin αvβ5+ human colorectal cancer LoVo cells and HLA-A*02:01+ integrin αvβ5− human small cell lung cancer NCI-H889 cells (Fig. S2).